Sandi Bresnick is a trial lawyer and Co-Chair of the Firm’s Global Life Sciences Practice. She focuses her practice on patent infringement and product liability actions and has particular experience litigating pharmaceutical and medical device cases.
Sandi has been recognized by Sandi has been repeatedly recognized by publications such as Chambers Global, Chambers USA, Legal 500, and IAM Patent 1000. Chambers, for example, has noted that Sandi “is an expert on the law concerning commercial life sciences . . . . Sources remark on her ‘“superior technical understanding.’” IAM Patent 1000 has reported she “has a knack for strategically positioning patent cases for trial. She also deftly handles product liability suits for life sciences entities, where her nuanced technical understanding proves a boon to clients.”
Sandi has taught Pharmaceutical Patent Law at Rutgers University School of Law and is a member of the Board of Directors of The Progeria Research Foundation, a non-profit research organization dedicated to developing treatments and a cure for progeria.